AgomAb Therapeutics
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About AgomAb Therapeutics
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities with the aim of increasing efficacy while avoiding systemic toxicities in order to overcome the limitations of prior therapeutic approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
/ 
Others were interested in
Frequently asked questions
To buy AgomAb Therapeutics stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for AgomAb Therapeutics by name or ticker, choose the number of shares, and place your order.
The ticker symbol for AgomAb Therapeutics is AGMB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
AgomAb Therapeutics has its primary listing on NASDAQ. You can trade AgomAb Therapeutics with a Saxo account, alongside thousands of other stocks worldwide.
Yes, AgomAb Therapeutics is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include AgomAb Therapeutics as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like AgomAb Therapeutics or others.